Evaluation of a rapid antigen test (Panbio™ COVID-19 Ag rapid test device) for SARS-CoV-2 detection in asymptomatic close contacts of COVID-19 patients.
Evaluation of a rapid antigen test (Panbio™ COVID-19 Ag rapid test device) for SARS-CoV-2 detection in asymptomatic close contacts of COVID-19 patients.
复制标题
DOI:
10.1016/j.cmi.2020.12.022
复制
发表时间:
2021-04
期刊:
影响因子:
--
通讯作者:
Navarro D
中科院分区:
文献类型:
--
作者:
Torres I;Poujois S;Albert E;Colomina J;Navarro D
There is limited information on the performance of rapid antigen detection (RAD) tests to identify SARS-CoV-2-infected asymptomatic individuals. In this field study, we evaluated the Panbio™ COVID-19 Ag Rapid Test Device (Abbott Diagnostics, Jena, Germany) for this purpose. A total of 634 individuals (355 female; median age, 37 years; range, 9–87) were enrolled. Two nasopharyngeal swabs were collected from household (n = 338) and non-household contacts (n = 296) of COVID-19 cases. RAD testing was carried out at the point of care. The RT-PCR test used was the TaqPath COVID-19 Combo Kit (Thermo Fisher Scientific, MA, USA). Household contacts were tested at a median of 2 days (range, 1–7) after diagnosis of the index case, whereas non-household contacts (n = 296) were tested at a median of 6 days (range, 1–7) after exposure. In total, 79 individuals (12.4%) tested positive by RT-PCR, of whom 38 (48.1%) yielded positive RAD results. The overall sensitivity and specificity of the RAD test was 48.1% (95% CI 37.4–58.9) and 100% (95% CI 99.3–100), respectively. Sensitivity was higher in household (50.8%; 95% CI 38.9–62.5) than in non-household (35.7%; 95% CI 16.3–61.2%) contacts. Individuals testing positive by RAD test were more likely (p < 0.001) to become symptomatic than their negative counterparts. The Panbio test displays low sensitivity in asymptomatic close contacts of COVID-19 patients, particularly in non-household contacts. Nonetheless, establishing the optimal timing for upper respiratory tract collection in this group seems imperative to pinpoint test sensitivity.
登录
查看更多内容
DOI:
10.1016/j.cmi.2020.11.004
发表时间:
2021-03
期刊:
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
影响因子:
--
作者:
Albert E;Torres I;Bueno F;Huntley D;Molla E;Fernández-Fuentes MÁ;Martínez M;Poujois S;Forqué L;Valdivia A;Solano de la Asunción C;Ferrer J;Colomina J;Navarro D
通讯作者:
Navarro D
DOI:
10.1016/j.jcv.2020.104659
发表时间:
2020-12
期刊:
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
影响因子:
--
作者:
Linares M;Pérez-Tanoira R;Carrero A;Romanyk J;Pérez-García F;Gómez-Herruz P;Arroyo T;Cuadros J
通讯作者:
Cuadros J
影响因子:
64.8
作者:
Woelfel, Roman;Corman, Victor M.;Wendtner, Clemens
通讯作者:
Wendtner, Clemens
影响因子:
11.8
作者:
Nguyen Van Vinh Chau;Vo Thanh Lam;Le Van Tan
通讯作者:
Le Van Tan
影响因子:
11.8
作者:
Baggio, Stephanie;L'Huillier, Arnaud G.;Eckerle, Isabella
通讯作者:
Eckerle, Isabella